
Clonidine can be utilized to address sleep problems in children with neurodisability, with initial dosing generally ranging from 1-6 mcg/kg/day split across doses. Published data supports its efficacy but highlights the need for individualized therapy due to limited large-scale evidence.
paediatrics, initial management, children, neurodisability, neurology, sleep, clonidine, dosage
paediatrics, initial management, children, neurodisability, neurology, sleep, clonidine, dosage
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
